
Keywords: ADA; antidrug antibody; ALI/ARDS; acute lung injury/acute respiratory distress syndromes; Ab; antibody; ADC; antibody drug conjugate; ADCC; antigen-dependent cellular cytotoxicity; BAL; bronchoalveolar lavage; BsAbs; bispecific antibodies; CCL; CC chemoki